Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shari Pilon-Thomas

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
Oncoimmunology|November 21, 2015
Triggering co-stimulation directly in melanoma tumor fragments drives CD8<sup>+</sup> tumor-infiltrating lymphocyte expansion with improved effector-memory propertiesJessica Ann Chacon, Amod A Sarnaik, Shari Pilon-Thomas, et al.
Cancer Immunology, Immunotherapy : CII|November 19, 2009
TNF-alpha-treated DC exacerbates disease in a murine tumor metastasis modelNasreen Vohra, Monique Verhaegen, Lisa Martin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 27, 2012
Blockade of myeloid-derived suppressor cells after induction of lymphopenia improves adoptive T cell therapy in a murine model of melanomaKrithika N Kodumudi, Amy Weber, Amod A Sarnaik, et al.
Cancer Cell|July 19, 2024
Tumor-infiltrating lymphocytes: A new hopeAmod A Sarnaik, Patrick Hwu, James J Mulé, et al.
Oncoimmunology|December 10, 2013
Continuous 4-1BB co-stimulatory signals for the optimal expansion of tumor-infiltrating lymphocytes for adoptive T-cell therapyJessica Ann Chacon, Shari Pilon-Thomas, Amod A Sarnaik, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2025
Optimizing the Efficacy of Vaccine-Induced Immunotherapy in MelanomasIbrahim Chamseddine, Manoj Kambara, Priya Bhatt, et al.
Cancer Journal (Sudbury, Mass.)|July 26, 2022
Current State of Cell Therapies for Genitourinary MalignanciesMohammed A Alkhouli, Sarah Bazargan, Shari Pilon-Thomas, et al.
Cancer Immunology, Immunotherapy : CII|November 30, 2005
Induction of anti-tumor immunity by vaccination with dendritic cells pulsed with anti-CD44 IgG opsonized tumor cellsShari Pilon-Thomas, Monique Verhaegen, Lisa Kuhn, et al.
Bulletin of Mathematical Biology|May 28, 2025
Optimizing the Efficacy of Vaccine-Induced Immunotherapy in MelanomasIbrahim Chamseddine, Manoj Kambara, Priya Bhatt, et al.
Convergent Science Physical Oncology|May 19, 2018
Evaluating the potential for maximized T cell redistribution entropy to improve abscopal responses to radiotherapyRachel Walker, Jonathan D Schoenfeld, Shari Pilon-Thomas, et al.
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
Oncoimmunology|November 21, 2015
Triggering co-stimulation directly in melanoma tumor fragments drives CD8<sup>+</sup> tumor-infiltrating lymphocyte expansion with improved effector-memory propertiesJessica Ann Chacon, Amod A Sarnaik, Shari Pilon-Thomas, et al.
Cancer Immunology, Immunotherapy : CII|November 19, 2009
TNF-alpha-treated DC exacerbates disease in a murine tumor metastasis modelNasreen Vohra, Monique Verhaegen, Lisa Martin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 27, 2012
Blockade of myeloid-derived suppressor cells after induction of lymphopenia improves adoptive T cell therapy in a murine model of melanomaKrithika N Kodumudi, Amy Weber, Amod A Sarnaik, et al.
Cancer Cell|July 19, 2024
Tumor-infiltrating lymphocytes: A new hopeAmod A Sarnaik, Patrick Hwu, James J Mulé, et al.
Oncoimmunology|December 10, 2013
Continuous 4-1BB co-stimulatory signals for the optimal expansion of tumor-infiltrating lymphocytes for adoptive T-cell therapyJessica Ann Chacon, Shari Pilon-Thomas, Amod A Sarnaik, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2025
Optimizing the Efficacy of Vaccine-Induced Immunotherapy in MelanomasIbrahim Chamseddine, Manoj Kambara, Priya Bhatt, et al.
Cancer Journal (Sudbury, Mass.)|July 26, 2022
Current State of Cell Therapies for Genitourinary MalignanciesMohammed A Alkhouli, Sarah Bazargan, Shari Pilon-Thomas, et al.
Cancer Immunology, Immunotherapy : CII|November 30, 2005
Induction of anti-tumor immunity by vaccination with dendritic cells pulsed with anti-CD44 IgG opsonized tumor cellsShari Pilon-Thomas, Monique Verhaegen, Lisa Kuhn, et al.
Bulletin of Mathematical Biology|May 28, 2025
Optimizing the Efficacy of Vaccine-Induced Immunotherapy in MelanomasIbrahim Chamseddine, Manoj Kambara, Priya Bhatt, et al.
Convergent Science Physical Oncology|May 19, 2018
Evaluating the potential for maximized T cell redistribution entropy to improve abscopal responses to radiotherapyRachel Walker, Jonathan D Schoenfeld, Shari Pilon-Thomas, et al.
Pageof 11